Abstract
Venous thromboembolic complications most often occur in cancer patients, which is a big problem for the doctor in each specific case and for the health care system in general.
 The article highlights the peculiarities of diagnosis, establishing the stage of the tumor process and risk factors for the occurrence of pulmonary embolism. Considerable attention is paid to the peculiarities of the selection of drugs and their dosage for the treatment of the specified cohort of patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
